Illicit cigarette purchasing after implementation of menthol cigarette bans in Canada: findings from the 2016–2018 ITC Four Country Smoking and Vaping Surveys
Tobacco Control · 2024
DOI: 10.1136/tc-2022-057697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tobacco Control, 2024. Verfasst von Janet Chung-Hall und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada jchunghall@uwaterloo.ca. Hauptthemen laut MEDLINE: Vaping, Tobacco Products. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, US National Cancer Institute, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Objective
To examine the impact of menthol cigarette bans on use and purchasing of illicit cigarettes among menthol and non-menthol smokers in seven Canadian provinces.
Methods
Data from 1098 non-menthol smokers and 138 menthol smokers in Canada who completed the ITC Four Country Smoking and Vaping Survey in 2016 (pre-ban) and 2018 (post-ban). Brand validation analysis was conducted to (1) compare self-reported use of menthols versus actual use of menthols as regular brand, and verify self-reported purchasing of menthols among pre-ban menthol smokers at post-ban; and (2) assess pre-post ban changes in purchasing of illicit cigarettes from First Nations reserves among non-menthol smokers and menthol smokers.
Results
Among the subset of 138 pre-ban menthol smokers, 36 (19.5%) reported smoking menthols at post-ban. Brand validation analyses showed that 19 (9.0%) were actually using a non-menthol brand; of the 17 (10.5%) who were actually using a menthol brand, 13 (7.9%) bought a menthol brand at last purchase, and 4 (2.6%) bought a non-menthol brand. Among the full sample of smokers who purchased cigarettes from First Nations reserves at both pre-ban and post-ban, there was no change in purchasing of menthols (n=9 menthol smokers; 51.2% vs 51.2%, p=1.00), non-menthols (n=1024 non-menthol smokers; 9.1% vs 8.7%, p=0.69) or all cigarettes (menthol+non-menthol) (n=1086 smokers; 9.7% vs 9.2%, p=0.56).
Conclusions
Actual rates of brand-verified menthol smoking were substantially lower than self-reported rates at post-ban. After Canada’s menthol ban, there was no increase in illicit purchasing of menthol or non-menthol cigarettes from First Nations reserves.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada jchunghall@uwaterloo.ca.
- Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.
- School of Public Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
- Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
ORCID-Profile: Janet Chung-Hall, Geoffrey T Fong, Gang Meng, Lorraine V Craig
Förderung
- NCI NIH HHS
- US National Cancer Institute
- Canadian Institutes of Health Research
- National Health and Medical Research Council of Australia
- Ontario Institute for Cancer Research
Zitieren
APA
Chung-Hall, J., Fong, G. T., Meng, G., & Craig, L. V. (2024). Illicit cigarette purchasing after implementation of menthol cigarette bans in Canada: findings from the 2016–2018 ITC Four Country Smoking and Vaping Surveys. Tobacco Control. https://doi.org/10.1136/tc-2022-057697
Vancouver
Chung-Hall J, Fong GT, Meng G, Craig LV. Illicit cigarette purchasing after implementation of menthol cigarette bans in Canada: findings from the 2016–2018 ITC Four Country Smoking and Vaping Surveys. Tobacco Control. 2024. doi:10.1136/tc-2022-057697
BibTeX
@article{ChungHall2024,
author = {Chung-Hall, Janet and Fong, Geoffrey T and Meng, Gang and Craig, Lorraine V},
title = {Illicit cigarette purchasing after implementation of menthol cigarette bans in Canada: findings from the 2016–2018 ITC Four Country Smoking and Vaping Surveys},
journal = {Tobacco Control},
year = {2024},
doi = {10.1136/tc-2022-057697}
}
EUVIMED